| Literature DB >> 30686982 |
Qianru He1, Mi Shen1, Fang Tong1, Meng Cong1, Shibo Zhang1, Yanpei Gong2, Fei Ding1.
Abstract
Fibroblasts (Fbs) effectively promote Schwann cells (SCs) migration, proliferation, and neurite regeneration. Whether Fbs express different motor and sensory phenotypes that regulate the cell behavior and peripheral nerve function has not been elucidated. The present study utilized the whole rat genome microarray analysis and identified a total of 121 differentially expressed genes between the primary cultured motor and sensory Fbs. The genes with high expression in sensory Fbs were related to proliferation, migration, chemotaxis, motility activation, protein maturation, defense response, immune system, taxis, and regionalization, while those with high expression in motor Fbs were related to neuron differentiation, segmentation, and pattern specification. Thus, the significant difference in the expression of some key genes was found to be associated with cell migration and proliferation, which was further validated by quantitative real-time PCR (qPCR). The cell proliferation or migration analysis revealed a higher rate of cell migration and proliferation of sensory Fbs than motor Fbs. Moreover, the downregulated expression of chemokine (C-X-C motif) ligand 10 (CXCL10) and chemokine (C-X-C motif) ligand 3 (CXCL3) suppressed the proliferation rate of sensory Fbs, while it enhanced that of the motor Fbs. However, the migration rate of both Fbs was suppressed by the downregulated expression of CXCL10 or CXCL3. Furthermore, a higher proportion of motor or sensory SCs migrated toward their respective (motor or sensory) Fbs; however, few motor or sensory SCs co-cultured with the other type of Fbs (sensory or motor, respectively), migrated toward the Fbs. The current findings indicated that Fbs expressed the distinct motor and sensory phenotypes involved in different patterns of gene expression, biological processes, and effects on SCs. Thus, this study would provide insights into the biological differences between motor and sensory Fbs, including the role in peripheral nerve regeneration.Entities:
Keywords: cell migration; cell proliferation; motor fibroblasts; peripheral nervous system; sensory fibroblasts
Year: 2019 PMID: 30686982 PMCID: PMC6333708 DOI: 10.3389/fnins.2018.01016
Source DB: PubMed Journal: Front Neurosci ISSN: 1662-453X Impact factor: 4.677
FIGURE 1Phase-contrast micrograph showed typical cell morphology of primary cultured motor (A) and sensory Fbs (F) (scale bar, 50 μm). Fluorescence microscope photograph (scale bar, 100 μm) of cultured motor (B–D) and sensory fibroblasts (G–I) showing immunostaining with antibody against Thy-1 (B,G, green), Hoechst 33342 nucleus staining (C,H, blue), and the merge of both staining (D,I), n = 9 rats. The FCA graph showing the percentage of Thy-1-positive cells (M2) of cultured motor (E) and sensory (J) fibroblasts, n = 10 rats.
FIGURE 2(A) Heatmap and cluster dendrogram of the 121 differentially expressed genes that had more than twofold changes (sensory fibroblasts/motor fibroblasts) in their expression of four replicates, n = 12 rats. (B) Histogram showing functional categorization of the 121 differentially expressed genes between motor and sensory fibroblasts according to their main biological functions collected from DAVID Bioinformatic Resources 6.7 (Rat) and Gene Ontology, in which the different functional categories of the higher expressed genes are shown on the ordinate, and the number of the higher expressed genes within each categories of sensory or motor fibroblasts is shown on the abscissa. (C) The qPCR data showing that Abcc9, Cxcl10, Cxcl3, Syk, C5ar1, Pf4, Ptgs1, presented the higher mRNA level in sensory fibroblasts than in motor fibroblasts. Data are expressed as means ± SEM of three independent experiments (each in triplicate). GAPDH served as an internal control. p = 0.009, p = 0.031, p = 0.047, p = 0.003, p = 0.027, p = 0.049, and p = 0.045, respectively, ∗p < 0.05, ∗∗p < 0.01 vs. motor Fbs, unpaired t-test, n = 9–10 rats.
Functional classification of upregulated genes in sensory fibroblasts.
| Genbank accession | Gene symbol | Gene name | Fold change | |
|---|---|---|---|---|
| NM_013028 | Shox2 | Short stature homeobox 2 | 3.3 | 0.022 |
| XM_578417 | Rerg | RAS-like, estrogen-regulated, growth-inhibitor | 2.9 | 0.001 |
| NM_139089 | Cxcl10 | Chemokine (C-X-C motif) ligand 10 | 2.8 | 0.006 |
| NM_017043 | Ptgs1 | Prostaglandin-endoperoxide synthase 1 | 2.6 | 0.027 |
| NM_030871 | Pde1a | Phosphodiesterase 1A, calmodulin-dependent | 2.2 | 0.014 |
| NM_001033998 | Itgal | Integrin, alpha L | 2.1 | 0.014 |
| NM_031512 | Il1b | Interleukin 1 beta | 2.1 | 0.040 |
| NM_012758 | Syk | Spleen tyrosine kinase | 2.1 | 0.032 |
| NM_022634 | Lst1 | Leukocyte specific transcript 1 | 2.1 | 0.011 |
| NM_001107031 | Slfn2 | Schlafen 2 | 2.1 | 0.005 |
| NM_013040 | Abcc9 | ATP-binding cassette, subfamily C (CFTR/MRP), member 9 | 2.7 | 0.024 |
| NM_001007729 | Pf4 | Platelet factor 4 | 2.7 | 0.004 |
| NM_138522 | Cxcl3 | Chemokine (C-X-C motif) ligand 3 | 2.4 | 0.019 |
| BC079460 | Ccl6 | Chemokine (C-C motif) ligand 6 | 2.2 | 0.002 |
| NM_031512 | Il1b | Interleukin 1 beta | 2.1 | 0.040 |
| NM_012758 | Syk | Spleen tyrosine kinase | 2.1 | 0.032 |
| NM_053619 | C5ar1 | Complement component 5a receptor 1 | 2.1 | 0.012 |
| NM_053647 | Cxcl2 | Chemokine (C-X-C motif) ligand 2 | 2.1 | 0.046 |
| NM_139089 | Cxcl10 | chemokine (C-X-C motif) ligand 10 | 2.8 | 0.006 |
| NM_013040 | Abcc9 | ATP-binding cassette, subfamily C (CFTR/MRP), member 9 | 2.7 | 0.024 |
| NM_001007729 | Pf4 | Platelet factor 4 | 2.7 | 0.004 |
| NM_138522 | Cxcl3 | Chemokine (C-X-C motif) ligand 3 | 2.4 | 0.019 |
| BC079460 | Ccl6 | Chemokine (C-C motif) ligand 6 | 2.2 | 0.002 |
| NM_031512 | Il1b | Interleukin 1 beta | 2.1 | 0.040 |
| NM_012758 | Syk | Spleen tyrosine kinase | 2.1 | 0.032 |
| NM_053619 | C5ar1 | Complement component 5a receptor 1 | 2.1 | 0.012 |
| NM_053647 | Cxcl2 | Chemokine (C-X-C motif) ligand 2 | 2.1 | 0.046 |
| NM_139089 | Cxcl10 | Chemokine (C-X-C motif) ligand 10 | 2.8 | 0.006 |
| NM_001007729 | Pf4 | Platelet factor 4 | 2.7 | 0.004 |
| NM_138522 | Cxcl3 | Chemokine (C-X-C motif) ligand 3 | 2.4 | 0.019 |
| BC079460 | Ccl6 | Chemokine (C-C motif) ligand 6 | 2.2 | 0.002 |
| NM_031512 | Il1b | Interleukin 1 beta | 2.1 | 0.040 |
| NM_012758 | Syk | Spleen tyrosine kinase | 2.1 | 0.032 |
| NM_053619 | C5ar1 | Complement component 5a receptor 1 | 2.1 | 0.012 |
| NM_001007612 | Ccl7 | Chemokine (C-C motif) ligand 7 | 2.1 | 0.038 |
| NM_053647 | Cxcl2 | Chemokine (C-X-C motif) ligand 2 | 2.1 | 0.046 |
| NM_031512 | Il1b | Interleukin 1 beta | 2.0 | 0.046 |
| NM_053572 | Cdhr1 | Cadherin-related family member 1 | 2.6 | 0.049 |
| NM_001033998 | Itgal | Integrin, alpha L | 2.1 | 0.014 |
| NM_012758 | Syk | Spleen tyrosine kinase | 2.1 | 0.032 |
| NM_013040 | Abcc9 | ATP-binding cassette, subfamily C (CFTR/MRP), member 9 | 2.7 | 0.024 |
| NM_016994 | C3 | Complement component 3 Toll-like receptor 7 | 2.6 | 0.001 |
| NM_001097582 | Tlr7 | Potassium inwardly-rectifying channel, subfamily J, member 8 | 2.5 | 0.002 |
| NM_017099 | Kcnj8 | Fc fragment of IgG, high affinity Ia, receptor (CD64) | 2.4 | 0.009 |
| NM_001100836 | Fcgr1a | Complement factor H | 2.2 | 0.008 |
| NM_130409 | Cfh | 2.1 | 0.006 | |
| NM_001007729 | Pf4 | Platelet factor 4 | 2.7 | 0.004 |
| NM_030871 | Pde1a | Phosphodiesterase 1A, calmodulin-dependent | 2.2 | 0.014 |
| NM_001100836 | Fcgr1a | Fc fragment of IgG, high affinity Ia, receptor (CD64) | 2.2 | 0.008 |
| NM_031512 | Il1b | Interleukin 1 beta | 2.1 | 0.040 |
| NM_053619 | C5ar1 | Complement component 5a receptor 1 | 2.1 | 0.012 |
| NM_012762 | Casp1 | Caspase 1 | 2.1 | 0.015 |
| NM_017043 | Ptgs1 | Prostaglandin-endoperoxide synthase 1 | 2.6 | 0.027 |
| XM_006225973 | Pram1 | PML-RARA regulated adaptor molecule 1 | 2.2 | 0.008 |
| NM_031512 | Il1b | Interleukin 1 beta | 2.1 | 0.040 |
| NM_012758 | Syk | Spleen tyrosine kinase | 2.1 | 0.032 |
| NM_012762 | Casp1 | Caspase 1 | 2.1 | 0.015 |
| NM_139089 | Cxcl10 | Chemokine (C-X-C motif) ligand 10 | 2.8 | 0.006 |
| NM_001007729 | Pf4 | Platelet factor 4 | 2.7 | 0.004 |
| NM_138522 | Cxcl3 | Chemokine (C-X-C motif) ligand 3 | 2.4 | 0.019 |
| BC079460 | Ccl6 | Chemokine (C-C motif) ligand 6 | 2.2 | 0.002 |
| NM_031512 | Il1b | Interleukin 1 beta | 2.1 | 0.040 |
| NM_012758 | Syk | Spleen tyrosine kinase | 2.1 | 0.032 |
| NM_053619 | C5ar1 | Complement component 5a receptor 1 | 2.1 | 0.012 |
| NM_001007612 | Ccl7 | Chemokine (C-C motif) ligand 7 | 2.1 | 0.038 |
| NM_053647 | Cxcl2 | Chemokine (C-X-C motif) ligand 2 | 2.1 | 0.046 |
| NM_013028 | Shox2 | short stature homeobox 2 | 3.3 | 0.022 |
| NM_012921 | Alx1 | ALX homeobox 1 | 2.0 | 0.049 |
| XM_006257585 | Zic3 | Zic family member 3 | 7.5 | 0.012 |
| NM_012921 | Alx1 | ALX homeobox 1 | 2.0 | 0.049 |
| NM_017043 | Ptgs1 | Prostaglandin-endoperoxide synthase 1 | 2.6 | 0.027 |
| XM_006225973 | Pram1 | PML-RARA regulated adaptor molecule 1 | 2.2 | 0.008 |
| NM_031512 | Il1b | Interleukin 1 beta | 2.1 | 0.040 |
| NM_012758 | Syk | Spleen tyrosine kinase | 2.1 | 0.032 |
| NM_012762 | Casp1 | Caspase 1 | 2.1 | 0.015 |
| NM_139089 | Cxcl10 | Chemokine (C-X-C motif) ligand 10 | 2.8 | 0.006 |
| NM_013040 | Abcc9 | ATP-binding cassette, subfamily C (CFTR/MRP), member 9 | 2.7 | 0.024 |
| NM_016994 | C3 | Complement component 3 | 2.6 | 0.001 |
| NM_001097582 | Tlr7 | Toll-like receptor 7 | 2.5 | 0.002 |
| NM_017099 | Kcnj8 | Potassium inwardly-rectifying channel, subfamily J, member 8 | 2.4 | 0.009 |
| NM_138522 | Cxcl3 | Chemokine (C-X-C motif) ligand 3 | 2.4 | 0.019 |
| FQ217794 | Cybb | Cytochrome b-245, beta polypeptide | 2.3 | 0.038 |
| NM_001100836 | Fcgr1a | Fc fragment of IgG, high affinity Ia, receptor (CD64) | 2.2 | 0.008 |
| NM_031512 | Il1b | Interleukin 1 beta | 2.1 | 0.040 |
| NM_130409 | Cfh | Complement factor H | 2.1 | 0.006 |
| NM_053619 | C5ar1 | Complement component 5a receptor 1 | 2.1 | 0.012 |
| NM_001007612 | Ccl7 | Chemokine (C-C motif) ligand 7 | 2.1 | 0.038 |
| NM_053647 | Cxcl2 | Chemokine (C-X-C motif) ligand 2 | 2.1 | 0.046 |
| NM_198769 | Tlr2 | Toll-like receptor 2 | 2.0 | 0.003 |
| NM_016994 | C3 | Complement component 3 | 2.6 | 0.001 |
| NM_130409 | Cfh | Complement factor H | 2.1 | 0.006 |
| NM_012762 | Casp1 | Caspase 1 | 2.1 | 0.015 |
Functional classification of upregulated genes in motor fibroblasts.
| Genbank accession | Gene symbol | Gene name | Fold change | |
|---|---|---|---|---|
| NM_153621 | Dab1 | Dab, reelin signal transducer, homolog 1 (Drosophila) | 0.5 | 0.007 |
| NM_017242 | Lsamp | Limbic system-associated membrane protein | 0.5 | 0.008 |
| XM_006232194 | Nlgn1 | Neuroligin 1 | 0.5 | 0.015 |
| NM_031069 | Nell1 | NEL-like 1 (chicken) | 0.4 | 0.002 |
| NM_012929 | Col2a1 | Collagen, type II, alpha 1 | 0.3 | 0.023 |
| XM_006232194 | Nlgn1 | Neuroligin 1 | 0.5 | 0.015 |
| NM_053601 | Nnat | Neuronatin | 0.4 | 0.003 |
| NM_031737 | Nkx6-1 | NK6 homeobox 1 | 0.3 | 1 × 10-4 |
| NM_053601 | Nnat | Neuronatin | 0.4 | 0.003 |
| NM_031737 | Nkx6-1 | NK6 homeobox 1 | 0.3 | 1 × 10-4 |
| NM_001007012 | Alx3 | ALX homeobox 3 | 0.4 | 0.036 |
| NM_012929 | Col2a1 | Collagen, type II, alpha 1 | 0.3 | 0.023 |
| NM_001107787 | Pax1 | Paired box 1 | 0.2 | 0.002 |
| NM_012999 | Pcsk6 | Proprotein convertase subtilisin/kexin type 6 | 0.5 | 0.000 |
| NM_001007012 | Alx3 | ALX homeobox 3 | 0.4 | 0.036 |
| NM_031069 | Nell1 | NEL-like 1 (chicken) | 0.4 | 0.002 |
| NM_012929 | Col2a1 | Collagen, type II, alpha 1 | 0.3 | 0.023 |
| NM_001007012 | Alx3 | ALX homeobox 3 | 0.4 | 0.036 |
| NM_012929 | Col2a1 | Collagen, type II, alpha 1 | 0.3 | 0.023 |
| NM_001107787 | Pax1 | Paired box 1 | 0.2 | 0.002 |
| NM_012999 | Pcsk6 | Proprotein convertase subtilisin/kexin type 6 | 0.5 | 1 × 10-4 |
| NM_001107787 | Pax1 | Paired box 1 | 0.2 | 0.002 |
| NM_012999 | Pcsk6 | Proprotein convertase subtilisin/kexin type 6 | 0.5 | 1 × 10-4 |
| NM_031737 | Nkx6-1 | NK6 homeobox 1 | 0.3 | 1 × 10-4 |
| NM_001107787 | Pax1 | Paired box 1 | 0.2 | 0.002 |
| NM_012999 | Pcsk6 | Proprotein convertase subtilisin/kexin type 6 | 0.5 | 1 × 10-4 |
| NM_001007012 | Alx3 | ALX homeobox 3 | 0.4 | 0.036 |
| NM_031737 | Nkx6-1 | NK6 homeobox 1 | 0.3 | 1 × 10-4 |
| NM_001107787 | Pax1 | Paired box 1 | 0.2 | 0.002 |
FIGURE 3The merge of EdU staining (red) and Hoechst 33342 staining (blue) for cultured motor (A) and sensory (B) fibroblasts, in which scale bar is 200 μm. (C) The histogram showing the percentage of EdU-positive nuclei in motor and sensory fibroblasts. p = 0.041, unpaired t-test, n = 9 rats. (D) Proliferation capacity of motor and sensory fibroblasts in three different cell density of 5K, 10K, 20K continuously monitored by RTCA for 48 h. Quantification of cell proliferation index of cultured sensory and motor fibroblasts in three different cell density of 5K (E), 10K (F), 20K (G). ∗p < 0.05 vs. motor fibroblasts, unpaired t-test, n = 14–15 rats.
FIGURE 4Images showing cultured sensory and motor fibroblasts migrating to the bottom surface of the trans-well membrane after 4 or 24h (A). Scale bar, 100 μm. (B) The histogram demonstrating the quantitative analysis in cell migration between cultured sensory and motor fibroblasts after 4 or 24 h. p = 0.0016 and p = 0.0011, respectively, unpaired t-test, n = 18–19 rats. Migration capacity of motor and sensory fibroblasts in different cell density of 20K, 40K continuously monitored by RTCA for 36 h (C). Quantification of cell migration index of cultured motor and sensory fibroblasts in two different cell density of 20K (D), 40K (E). ∗p < 0.05, ∗∗p < 0.01 vs. motor fibroblasts, unpaired t-test, n = 18 rats.
FIGURE 5(A,B) The knockdown efficiency of Cxcl10 and Cxcl3-targeting siRNAs was detected in primary motor and sensory fibroblasts, three siRNAs for each target. Motor and sensory fibroblasts were transfected with NTC siRNA or with Cxcl10 and Cxcl3-specific siRNA, their mRNA levels were detected by qPCR after transfection for 48 h. ∗p < 0.05, ∗∗p < 0.01 vs. motor fibroblasts Con, ###p < 0.001 vs. sensory fibroblasts Con, n = 9 rats. (C,D) Motor and sensory fibroblasts were transfected with NTC siRNA or with Cxcl10 and Cxcl3-specific siRNA for 48 h. The fibroblasts extracts were subjected to Western blot to test the levels of these endogenous proteins; β-actin served as an internal control. Quantification of protein expression in motor and sensory fibroblasts after transfection with NTC siRNA or with Cxcl10 and Cxcl3-specific siRNA for 48 h (E,F). Data are presented as means ± SEM. ∗p < 0.05, ∗∗∗p < 0.001 compared with Motor fibroblasts Con, #p < 0.05, ##p < 0.01, ###p < 0.001 compared with Sensory fibroblasts Con, n = 9 rats.
FIGURE 6Proliferation (A) and migration (C) capacity of motor and sensory fibroblasts after transfection with NTC siRNA or with Cxcl10-specific siRNA for 48 h continuously monitored by RTCA for 48 or 36 h. Quantification of cell proliferation (B) and migration (D) index of cultured motor and sensory fibroblasts after transfection with NTC siRNA or with Cxcl10-specific siRNA for 48 h. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 compared with Sensory Fbs Con, #p < 0.05, ##p < 0.01, compared with Motor Fbs Con, n = 21 rats for cell proliferation assay, n = 24 rats for cell migration assay.
FIGURE 7Proliferation (A) and migration (C) capacity of motor and sensory fibroblasts after transfection with NTC siRNA or with Cxcl3-specific siRNA for 48 h continuously monitored by RTCA for 48 or 36 h. Quantification of cell proliferation (B) and migration (D) index of cultured motor and sensory fibroblasts after transfection with NTC siRNA or with Cxcl3-specific siRNA for 48 h. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 compared with Sensory Fbs Con, #p < 0.05, ##p < 0.01, compared with Motor Fbs Con, n = 21 rats for cell proliferation assay, n = 28 rats for cell migration assay.
FIGURE 8(A–F) Images showing motor and sensory SCs and motor and sensory SCs co-cultured with motor and sensory Fbs migrating to the bottom surface of the trans-well membrane after co-cultured for 12 h. Scale bar, 20 μm. (G) Quantification of SCs migrating to the bottom surface of the trans-well membrane. p = 0.0001 and p = 0.0005, respectively, ∗∗∗p < 0.001 compared with M-SCs group, one-way ANOVA, n = 18–19 rats.